Proteomics and NF-κB: An update

Expert Review of Proteomics

Volumn 10, Issue 2, 2013, Pages 189-204

  Niederberger, Ellen ^a   Geisslinger, Gerd ^a  

^a UNIVERSITY HOSPITAL FRANKFURT   (Germany)

Author keywords

cancer; inflammation; NF B; proteomics

Indexed keywords

ARTEMISIA DRACUNCULUS EXTRACT; CD71 ANTIGEN; CISPLATIN; DOXORUBICIN; ECHINACEA EXTRACT; I KAPPA B KINASE ALPHA; IFOSFAMIDE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERFERON REGULATORY FACTOR 3; LIPOCORTIN 4; METHOTREXATE; MYELOID DIFFERENTIATION FACTOR 88; PHOSPHOPROTEIN; PLANT EXTRACT; PMI 5011; PROTEIN 14 3 3; PROTEIN P100; PROTEIN P52; STAT3 PROTEIN; STAT5B PROTEIN; SYNAPTOTAGMIN I; SYNUCLEIN; TERMINALIA CHEBULA EXTRACT; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 3; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR 7; TOLL LIKE RECEPTOR 8; TOLL LIKE RECEPTOR 9; TRANSCRIPTION FACTOR RELB; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR 6; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; APOPTOSIS; ATHEROSCLEROSIS; AUTOIMMUNE DISEASE; B CELL LYMPHOMA; B LYMPHOCYTE ACTIVATION; BREAST CANCER; BURKITT LYMPHOMA; CALCIUM SIGNALING; CANCER COMBINATION CHEMOTHERAPY; CANCER PATIENT; CARCINOGENESIS; CELL ACTIVATION; CYSTIC FIBROSIS; DEGENERATIVE DISEASE; DIABETES MELLITUS; ENDOMETRIUM CANCER; ENZYME REGULATION; GEL ELECTROPHORESIS; GENETIC TRANSCRIPTION; GLAUCOMA; GROWTH REGULATION; HEMATOLOGIC MALIGNANCY; HUMAN; HUMORAL IMMUNITY; IMMUNE RESPONSE; IMMUNITY; INFECTION; INFLAMMATION; LIPID RAFT; LIVER CELL CARCINOMA; LUNG CANCER; LYMPHOMA; MALIGNANT NEOPLASTIC DISEASE; MASS SPECTROMETRY; MYELOPROLIFERATIVE DISORDER; NASOPHARYNX CARCINOMA; NEOPLASM; NON INSULIN DEPENDENT DIABETES MELLITUS; OSTEOSARCOMA; OVARY CANCER; PARKINSON DISEASE; PROSTATE CANCER; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN INTERACTION; PROTEIN MICROARRAY; PROTEIN MODIFICATION; PROTEIN STABILITY; PROTEIN TARGETING; PROTEOMICS; REVIEW; RHEUMATOID ARTHRITIS; SHEAR STRESS; SIGNAL TRANSDUCTION; THYROID CARCINOMA; UBIQUITINATION; UTERINE CERVIX CANCER;

HUMANS; MODELS, BIOLOGICAL; NF-KAPPA B; PROTEOMICS; SIGNAL TRANSDUCTION;

EID: 84876140893     PISSN: 14789450     EISSN: 17448387     Source Type: Journal    
DOI: 10.1586/epr.13.5     Document Type: Review

References (118)

1. Karin M, Yamamoto Y, Wang QM. The IKK NF-κB system: A treasure trove for drug development. Nat. Rev. Drug Discov. 3(1), 17-26 (2004
2. Yamamoto Y, Gaynor RB. IκB kinases: Key regulators of the NF-κB pathway. Trends Biochem. Sci. 29(2), 72-79 (2004
3. Pahl HL. Activators and target genes of Rel/NF-κB transcription factors. Oncogene 18(49), 6853-6866 (1999
4. Häcker H, Karin M. Regulation and function of IKK and IKK-related kinases. Sci. STKE 2006(357), re13 (2006
5. Viatour P, Merville MP, Bours V, Chariot A. Phosphorylation of NF-κB and IκB proteins: Implications in cancer and inflammation. Trends Biochem. Sci. 30(1), 43-52 (2005
6. Peters RT, Maniatis T. A new family of IKK-related kinases may function as IκB kinase kinases. Biochim. Biophys. Acta 1471(2), M57-M62 (2001
7. Shimada T, Kawai T, Takeda K et al. IKK-i, a novel lipopolysaccharide- inducible kinase that is related to IκB kinases. Int. Immunol. 11(8), 1357-1362 (1999
8. Buss H, Dörrie A, Schmitz ML, Hoffmann E, Resch K, Kracht M. Constitutive and interleukin-1-inducible phosphorylation of p65 NF-{κ}B at serine 536 is mediated by multiple protein kinases including I{κ}B kinase (IKK)-{α}, IKK{β}, IKK{ε}, TRAF family memberassociated (TANK)-binding kinase 1 (TBK1), and an unknown kinase and couples p65 to TATA-binding proteinassociated factor II31-mediated interleukin- 8 transcription. J. Biol. Chem. 279(53), 55633-55643 (2004
9. Adli M, Baldwin AS. IKK-i/IKKε controls constitutive, cancer cell-associated NF-κB activity via regulation of Ser-536 p65/RelA phosphorylation. J. Biol. Chem. 281(37), 26976-26984 (2006
10. Mattioli I, Geng H, Sebald A et al. Inducible phosphorylation of NF-κB p65 at serine 468 by T cell costimulation is mediated by IKK ε. J. Biol. Chem. 281(10), 6175-6183 (2006
11. Harris J, Olière S, Sharma S et al. Nuclear accumulation of cRel following C-terminal phosphorylation by TBK1/IKK ε. J. Immunol. 177(4), 2527-2535 (2006
12. Sharma S, tenOever BR, Grandvaux N, Zhou GP, Lin R, Hiscott J. Triggering the interferon antiviral response through an IKK-related pathway. Science 300(5622), 1148-1151 (2003
13. McWhirter SM, Fitzgerald KA, Rosains J, Rowe DC, Golenbock DT, Maniatis T. IFN-regulatory factor 3-dependent gene expression is defective in Tbk1-deficient mouse embryonic fibroblasts. Proc. Natl Acad. Sci. USA 101(1), 233-238 (2004
14. Bassères DS, Baldwin AS. Nuclear factor-κB and inhibitor of κB kinase pathways in oncogenic initiation and progression. Oncogene 25(51), 6817-6830 (2006
15. Dutta J, Fan Y, Gupta N, Fan G, Gélinas C. Current insights into the regulation of programmed cell death by NF-κB. Oncogene 25(51), 6800-6816 (2006
16. Monaco C, Paleolog E. Nuclear factor κB: A potential therapeutic target in atherosclerosis and thrombosis. Cardiovasc. Res. 61(4), 671-682 (2004
17. Niederberger E, Schmidtko A, Gao W, Kühlein H, Ehnert C, Geisslinger G. Impaired acute and inflammatory nociception in mice lacking the p50 subunit of NF-κB. Eur. J. Pharmacol. 559(1), 55-60 (2007
18. Tegeder I, Niederberger E, Schmidt R et al. Specific inhibition of IκB kinase reduces hyperalgesia in inflammatory and neuropathic pain models in rats. J. Neurosci. 24(7), 1637-1645 (2004
19. Möser CV, Kynast K, Baatz K et al. The protein kinase IKKε is a potential target for the treatment of inflammatory hyperalgesia. J. Immunol. 187(5), 2617-2625 (2011
20. Alberio T, Bossi AM, Milli A et al. Proteomic analysis of dopamine and a-synuclein interplay in a cellular model of Parkinson's disease pathogenesis. FEBS J. 277(23), 4909-4919 (2010
21. Di Michele M, Peeters K, Loyen S et al. Pituitary adenylate cyclase-activating polypeptide (PACAP) impairs the regulation of apoptosis in megakaryocytes by activating NF-κB: A proteomic study. Mol. Cell Proteomics 11(1), M111.007625 (2012
22. Yin SY, Wang WH, Wang BX et al. Stimulatory effect of Echinacea purpurea extract on the trafficking activity of mouse dendritic cells: Revealed by genomic and proteomic analyses. BMC Genomics 11, 612 (2010
23. Hanash S. Disease proteomics. Nature 422(6928), 226-232 (2003
24. Banks RE, Dunn MJ, Hochstrasser DF et al. Proteomics: New perspectives, new biomedical opportunities. Lancet 356(9243), 1749-1756 (2000
25. Tieri P, Termanini A, Bellavista E, Salvioli S, Capri M, Franceschi C. Charting the NF-κB pathway interactome map. PLoS ONE 7(3), e32678 (2012
26. Niederberger E, Geisslinger G. Analysis of NF-κB signaling pathways by proteomic approaches. Expert Rev. Proteomics 7(2), 189-203 (2010
27. Zhou G, Li H, DeCamp D et al. 2D differential in-gel electrophoresis for the identification of esophageal scans cell cancer-specific protein markers. Mol. Cell Proteomics 1(2), 117-124 (2002
28. Karas M, Hillenkamp F. Laser desorption ionization of proteins with molecular masses exceeding 10,000 daltons. Anal. Chem. 60(20), 2299-2301 (1988
29. Whitehouse CM, Dreyer RN, Yamashita M, Fenn JB. Electrospray interface for liquid chromatographs and mass spectrometers. Anal. Chem. 57(3), 675-679 (1985
30. Merchant M, Weinberger SR. Recent advancements in surface-enhanced laser desorption/ionization-time of flight-mass spectrometry. Electrophoresis 21(6), 1164-1177 (2000
31. Fournier ML, Gilmore JM, Martin-Brown SA, Washburn MP. Multidimensional separations-based shotgun proteomics. Chem. Rev. 107(8), 3654-3686 (2007
32. Puig O, Caspary F, Rigaut G et al. The tandem affinity purification (TAP) method: A general procedure of protein complex purification. Methods 24(3), 218-229 (2001
33. Bauch A, Superti-Furga G. Charting protein complexes, signaling pathways, and networks in the immune system. Immunol. Rev. 210, 187-207 (2006
34. Ong SE, Blagoev B, Kratchmarova I et al. Stable isotope labeling by amino acids in cell culture, SILAC, as a simple and accurate approach to expression proteomics. Mol. Cell Proteomics 1(5), 376-386 (2002
35. Haab BB, Dunham MJ, Brown PO. Protein microarrays for highly parallel detection and quantitation of specific proteins and antibodies in complex solutions. Genome Biol. 2(2), RESEARCH0004 (2001
36. Knezevic V, Leethanakul C, Bichsel VE et al. Proteomic profiling of the cancer microenvironment by antibody arrays. Proteomics 1(10), 1271-1278 (2001
37. Paweletz CP, Charboneau L, Bichsel VE et al. Reverse phase protein microarrays which capture disease progression show activation of pro-survival pathways at the cancer invasion front. Oncogene 20(16), 1981-1989 (2001
38. Zhu H, Bilgin M, Snyder M. Proteomics. Annu. Rev. Biochem. 72, 783-812 (2003
39. Schubert W, Bonnekoh B, Pommer AJ et al. Analyzing proteome topology and function by automated multidimensional fluorescence microscopy. Nat. Biotechnol. 24(10), 1270-1278 (2006
40. Linke B, Pierre S, Coste O et al. Toponomics analysis of drug-induced changes in arachidonic acid-dependent signaling pathways during spinal nociceptive processing. J. Proteome Res. 8(10), 4851-4859 (2009
41. Chien CT, Bartel PL, Sternglanz R, Fields S. The two-hybrid system: A method to identify and clone genes for proteins that interact with a protein of interest. Proc. Natl Acad. Sci. USA 88(21), 9578-9582 (1991
42. Ross PL, Huang YN, Marchese JN et al. Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents. Mol. Cell Proteomics 3(12), 1154-1169 (2004
43. Hjerpe R, Aillet F, Lopitz-Otsoa F, Lang V, England P, Rodriguez MS. Efficient protection and isolation of ubiquitylated proteins using tandem ubiquitin-binding entities. EMBO Rep. 10(11), 1250-1258 (2009
44. Fenner BJ, Scannell M, Prehn JH. Expanding the substantial interactome of NEMO using protein microarrays. PLoS ONE 5(1), e8799 (2010
45. Kenneth NS, Mudie S, Naron S, Rocha S. TfR1 interacts with the IKK complex and is involved in IKK-NF-κB signalling. Biochem. J. 449(1), 275-284 (2013
46. Da Silva-Ferrada E, Torres-Ramos M, Aillet F et al. Role of monoubiquitylation on the control of IκBa degradation and NF-κB activity. PLoS ONE 6(10), e25397 (2011
47. Gerke V, Moss SE. Annexins: From structure to function. Physiol. Rev. 82(2), 331-371 (2002
48. Fatimathas L, Moss SE. Annexins as disease modifiers. Histol. Histopathol. 25(4), 527-532 (2010
49. Jeon YJ, Kim DH, Jung H et al. Annexin A4 interacts with the NF-κB p50 subunit and modulates NF-κB transcriptional activity in a Ca2+-dependent manner. Cell. Mol. Life Sci. 67(13), 2271-2281 (2010
50. Lin Q, Lai R, Chirieac LR et al. Constitutive activation of JAK3/STAT3 in colon carcinoma tumors and cell lines: Inhibition of JAK3/STAT3 signaling induces apoptosis and cell cycle arrest of colon carcinoma cells. Am. J. Pathol. 167(4), 969-980 (2005
51. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 19(21), 2474-2488 (2000
52. Wu Z, Zhang X, Yang J et al. Nuclear protein IκB-ζ inhibits the activity of STAT3. Biochem. Biophys. Res. Commun. 387(2), 348-352 (2009
53. Freed JK, Greene AS. Proteomic analysis of shear stress-mediated protection from TNF-α in endothelial cells. Microcirculation 17(4), 259-270 (2010
54. Butt AQ, Ahmed S, Maratha A, Miggin SM. 14-3-3e and 14-3-3s inhibit Toll-like receptor (TLR)-mediated proinflammatory cytokine induction. J. Biol. Chem. 287(46), 38665-38679 (2012
55. Fessler MB, Arndt PG, Frasch SC et al. Lipid rafts regulate lipopolysaccharideinduced activation of Cdc42 and inflammatory functions of the human neutrophil. J. Biol. Chem. 279(38), 39989-39998 (2004
56. Simons K, Ikonen E. Functional rafts in cell membranes. Nature 387(6633), 569-572 (1997
57. Triantafilou M, Miyake K, Golenbock DT, Triantafilou K. Mediators of innate immune recognition of bacteria concentrate in lipid rafts and facilitate lipopolysaccharide-induced cell activation. J. Cell. Sci. 115(Pt 12), 2603-2611 (2002
58. Dhungana S, Merrick BA, Tomer KB, Fessler MB. Quantitative proteomics analysis of macrophage rafts reveals compartmentalized activation of the proteasome and of proteasome-mediated ERK activation in response to lipopolysaccharide. Mol. Cell Proteomics 8(1), 201-213 (2009
59. Fujii K, Nakamura S, Takahashi K, Inagaki F. Systematic characterization by mass spectrometric analysis of phosphorylation sites in IRF-3 regulatory domain activated by IKK-i. J. Proteomics 73(6), 1196-1203 (2010
60. Li S, Wang L, Berman M, Kong YY, Dorf ME. Mapping a dynamic innate immunity protein interaction network regulating type I interferon production. Immunity 35(3), 426-440 (2011
61. Kondo T, Watanabe M, Hatakeyama S. TRIM59 interacts with ECSIT and negatively regulates NF-κB and IRF-3/7- mediated signal pathways. Biochem. Biophys. Res. Commun. 422(3), 501-507 (2012
62. Stempin CC, Chi L, Giraldo-Vela JP, High AA, Häcker H, Redecke V. The E3 ubiquitin ligase mind bomb-2 (MIB2) protein controls B-cell CLL/lymphoma 10 (BCL10)-dependent NF-κB activation. J. Biol. Chem. 286(43), 37147-37157 (2011
63. Gunawardena HP, Huang Y, Kenjale R, Wang H, Xie L, Chen X. Unambiguous characterization of site-specific phosphorylation of leucine-rich repeat Fli-I-interacting protein 2 (LRRFIP2) in Toll-like receptor 4 (TLR4)-mediated signaling. J. Biol. Chem. 286(13), 10897-10910 (2011
64. Shkoda A, Town JA, Griese J et al. The germinal center kinase TNIK is required for canonical NF-κB and JNK signaling in B-cells by the EBV oncoprotein LMP1 and the CD40 receptor. PLoS Biol. 10(8), e1001376 (2012
65. Ryu MJ, Anikin V, Hong SH et al. Activation of NF-κB by alloferon through down-regulation of antioxidant proteins and IκBα. Mol. Cell. Biochem. 313(1-2), 91-102 (2008
66. Bouwmeester T, Bauch A, Ruffner H et al. A physical and functional map of the human TNF-α/NF-κ B signal transduction pathway. Nat. Cell Biol. 6(2), 97-105 (2004
67. Yang X, Luo C, Cai J et al. Neurodegenerative and inflammatory pathway components linked to TNF-α/TNFR1 signaling in the glaucomatous human retina. Invest. Ophthalmol. Vis. Sci. 52(11), 8442-8454 (2011
68. Mattaliano MD, Wooters J, Shih HH, Paulsen JE. ROCK2 associates with lectin-like oxidized LDL receptor-1 and mediates oxidized LDL-induced IL-8 production. Am. J. Physiol. Cell Physiol. 298(5), C1180-C1187 (2010
69. Sun XG, Fu XQ, Cai HB et al. Proteomic analysis of protective effects of polysaccharides from Salvia miltiorrhiza against immunological liver injury in mice. Phytother. Res. 25(7), 1087-1094 (2011
70. Popova TG, Turell MJ, Espina V et al. Reverse-phase phosphoproteome analysis of signaling pathways induced by Rift Valley fever virus in human small airway epithelial cells. PLoS ONE 5(11), e13805 (2010
71. Emmott E, Rodgers MA, Macdonald A, McCrory S, Ajuh P, Hiscox JA. Quantitative proteomics using stable isotope labeling with amino acids in cell culture reveals changes in the cytoplasmic, nuclear, and nucleolar proteomes in Vero cells infected with the coronavirus infectious bronchitis virus. Mol. Cell Proteomics 9(9), 1920-1936 (2010
72. Han Z, Boyle DL, Manning AM, Firestein GS. AP-1 and NF-κB regulation in rheumatoid arthritis and murine collageninduced arthritis. Autoimmunity 28(4), 197-208 (1998
73. Podolin PL, Callahan JF, Bolognese BJ et al. Attenuation of murine collageninduced arthritis by a novel, potent, selective small molecule inhibitor of IκB kinase 2, TPCA-1 (2-[(aminocarbonyl) amino]-5-(4-fluorophenyl)-3- thiophenecarboxamide), occurs via reduction of proinflammatory cytokines and antigeninduced T cell proliferation. J. Pharmacol. Exp. Ther. 312(1), 373-381 (2005
74. McIntyre KW, Shuster DJ, Gillooly KM et al. A highly selective inhibitor of I κ B kinase, BMS-345541, blocks both joint inflammation and destruction in collageninduced arthritis in mice. Arthritis Rheum. 48(9), 2652-2659 (2003
75. Turner-Brannen E, Choi KY, Lippert DN et al. Modulation of interleukin-1β-induced inflammatory responses by a synthetic cationic innate defence regulator peptide, IDR-1002, in synovial fibroblasts. Arthritis Res. Ther. 13(4), R129 (2011
76. Lu MC, Lai NS, Yu HC, Huang HB, Hsieh SC, Yu CL. Anti-citrullinated protein antibodies bind surface-expressed citrullinated Grp78 on monocyte/ macrophages and stimulate tumor necrosis factor α production. Arthritis Rheum. 62(5), 1213-1223 (2010
77. Kerem B, Rommens JM, Buchanan JA et al. Identification of the cystic fibrosis gene: Genetic analysis. Science 245(4922), 1073-1080 (1989
78. Pollard HB, Ji XD, Jozwik C, Jacobowitz DM. High abundance protein profiling of cystic fibrosis lung epithelial cells. Proteomics 5(8), 2210-2226 (2005
79. Pollard HB, Eidelman O, Jozwik C et al. De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells. Mol. Cell Proteomics 5(9), 1628-1637 (2006
80. Baud V, Karin M. Is NF-κB a good target for cancer therapy? Hopes and pitfalls. Nat. Rev. Drug Discov. 8(1), 33-40 (2009
81. Xiao G, Rabson AB, Young W, Qing G, Qu Z. Alternative pathways of NF-κB activation: A double-edged sword in health and disease. Cytokine Growth Factor Rev. 17(4), 281-293 (2006
82. Arabi A, Ullah K, Branca RM et al. Proteomic screen reveals Fbw7 as a modulator of the NF-κB pathway. Nat. Commun. 3, 976 (2012
83. Harley CB, Futcher AB, Greider CW. Telomeres shorten during ageing of human fibroblasts. Nature 345(6274), 458-460 (1990
84. Chien Y, Scuoppo C, Wang X et al. Control of the senescence-associated secretory phenotype by NF-κB promotes senescence and enhances chemosensitivity. Genes Dev. 25(20), 2125-2136 (2011
85. Uemura N, Nakanishi Y, Kato H, Nagino M, Hirohashi S, Kondo T. Antibody-based proteomics for esophageal cancer: Identification of proteins in the nuclear factor-κB pathway and mitotic checkpoint. Cancer Sci. 100(9), 1612-1622 (2009
86. Deeb SJ, D'Souza RC, Cox J, Schmidt- Supprian M, Mann M. Super-SILAC allows classification of diffuse large B-cell lymphoma subtypes by their protein expression profiles. Mol. Cell Proteomics 11(5), 77-89 (2012
87. Gemoll T, Habermann JK, Lahmann J et al. Protein profiling of genomic instability in endometrial cancer. Cell. Mol. Life Sci. 69(2), 325-333 (2012
88. Li GP, Wang H, Lai YK et al. Proteomic profiling between CNE-2 and its strongly metastatic subclone S-18 and functional characterization of HSP27 in metastasis of nasopharyngeal carcinoma. Proteomics 11(14), 2911-2920 (2011
89. Gimm O. Thyroid cancer. Cancer Lett. 163(2), 143-156 (2001
90. Pacifico F, Paolillo M, Chiappetta G et al. RbAp48 is a target of nuclear factor-κB activity in thyroid cancer. J. Clin. Endocrinol. Metab. 92(4), 1458-1466 (2007
91. Liu J, Brown RE. Morphoproteomic confirmation of an activated nuclear factor-κBp65 pathway in follicular thyroid carcinoma. Int. J. Clin. Exp. Pathol. 5(3), 216-223 (2012
92. Bos PD, Zhang XH, Nadal C et al. Genes that mediate breast cancer metastasis to the brain. Nature 459(7249), 1005-1009 (2009
93. Li F, Glinskii OV, Zhou J et al. Identification and analysis of signaling networks potentially involved in breast carcinoma metastasis to the brain. PLoS One 6(7), e21977 (2011
94. Martín B, Aragüés R, Sanz R et al. Biological pathways contributing to organ-specific phenotype of brain metastatic cells. J. Proteome Res. 7(3), 908-920 (2008
95. Wei L, Wang Z, Cui T et al. Proteomic analysis of cervical cancer cells treated with adenovirus-mediated MDA-7. Cancer Biol. Ther. 7(4), 510-516 (2008
96. Gkiafi Z, Panayotou G. Comparative proteomic analysis implicates COMMD proteins as Epstein-Barr virus targets in the BL41 Burkitt's lymphoma cell line. J. Proteome Res. 10(7), 2959-2968 (2011
97. Thorgeirsson SS, Grisham JW. Molecular pathogenesis of human hepatocellular carcinoma. Nat. Genet. 31(4), 339-346 (2002
98. Fang C, Zhao C, Liu X, Yang P, Lu H. Protein alteration of HepG2.2.15 cells induced by iron overload. Proteomics 12(9), 1378-1390 (2012
99. Yu Y, Shen H, Yu H et al. Systematic proteomic analysis of human hepotacellular carcinoma cells reveals molecular pathways and networks involved in metastasis. Mol. Biosyst. 7(6), 1908-1916 (2011
100. Alexopoulos LG, Saez-Rodriguez J, Cosgrove BD, Lauffenburger DA, Sorger PK. Networks inferred from biochemical data reveal profound differences in Toll-like receptor and inflammatory signaling between normal and transformed hepatocytes. Mol. Cell Proteomics 9(9), 1849-1865 (2010
101. Sánchez-Quiles V, Santamaría E, Segura V, Sesma L, Prieto J, Corrales FJ. Prohibitin deficiency blocks proliferation and induces apoptosis in human hepatoma cells: Molecular mechanisms and functional implications. Proteomics 10(8), 1609-1620 (2010
102. Ferlay J, Autier P, Boniol M, Heanue M, Colombet M, Boyle P. Estimates of the cancer incidence and mortality in Europe in 2006. Ann. Oncol. 18(3), 581-592 (2007
103. Palayoor ST, Youmell MY, Calderwood SK, Coleman CN, Price BD. Constitutive activation of IκB kinase α and NF-κB in prostate cancer cells is inhibited by ibuprofen. Oncogene 18(51), 7389-7394 (1999
104. Seo SI, Song SY, Kang MR et al. Immunohistochemical analysis of NF-κB signaling proteins IKKε, p50/p105, p52/p100 and RelA in prostate cancers. APMIS 117(8), 623-628 (2009
105. Martinez HD, Hsiao JJ, Jasavala RJ, Hinkson IV, Eng JK, Wright ME. Androgen-sensitive microsomal signaling networks coupled to the proliferation and differentiation of human prostate cancer cells. Genes Cancer 2(10), 956-978 (2011
106. Endoh K, Nishi M, Ishiguro H et al. Identification of phosphorylated proteins involved in the oncogenesis of prostate cancer via Pin1-proteomic analysis. Prostate 72(6), 626-637 (2012
107. Lee ST, Wu YL, Chien LH, Chen ST, Tzeng YK, Wu TF. Proteomic exploration of the impacts of pomegranate fruit juice on the global gene expression of prostate cancer cell. Proteomics 12(21), 3251-3262 (2012
108. Pierce A, Williamson A, Jaworska E et al. Identification of nuclear protein targets for six leukemogenic tyrosine kinases governed by post-translational regulation. PLoS ONE 7(6), e38928 (2012
109. Agarwal NK, Mueller GA, Mueller C, Streich JH, Asif AR, Dihazi H. Expression proteomics of acute promyelocytic leukaemia cells treated with methotrexate. Biochim. Biophys. Acta 1804(4), 918-928 (2010
110. Ferguson WS, Goorin AM. Current treatment of osteosarcoma. Cancer Invest. 19(3), 292-315 (2001
111. Delepine N, Delepine G, Bacci G, Rosen G, Desbois JC. Influence of methotrexate dose intensity on outcome of patients with high grade osteogenic osteosarcoma. Analysis of the literature. Cancer 78(10), 2127-2135 (1996
112. Bielack SS, Kempf-Bielack B, Delling G et al. Prognostic factors in high-grade osteosarcoma of the extremities or trunk: An analysis of 1,702 patients treated on neoadjuvant cooperative osteosarcoma study group protocols. J. Clin. Oncol. 20(3), 776-790 (2002
113. Xie XB, Yin JQ, Wen LL et al. Critical role of heat shock protein 27 in bufalin-induced apoptosis in human osteosarcomas: A proteomic-based research. PLoS ONE 7(10), e47375 (2012
114. Jinawath N, Vasoontara C, Jinawath A et al. Oncoproteomic analysis reveals co-upregulation of RELA and STAT5 in carboplatin resistant ovarian carcinoma. PLoS ONE 5(6), e11198 (2010
115. Salnikow K, Zhitkovich A. Genetic and epigenetic mechanisms in metal carcinogenesis and cocarcinogenesis: Nickel, arsenic, and chromium. Chem. Res. Toxicol. 21(1), 28-44 (2008
116. Li Y, Xu Y, Ling M et al. mot-2-mediated cross talk between nuclear factor-B and p53 is involved in arsenite-induced tumorigenesis of human embryo lung fibroblast cells. Environ. Health Perspect. 118(7), 936-942 (2010
117. Kheterpal I, Coleman L, Ku G, Wang ZQ, Ribnicky D, Cefalu WT. Regulation of insulin action by an extract of Artemisia dracunculus L. in primary human skeletal muscle culture: A proteomics approach. Phytother. Res. 24(9), 1278-1284 (2010
118. Das ND, Jung KH, Park JH et al. Proteomic analysis of Terminalia chebula extract-dependent changes in human lymphoblastic T cell protein expression. J. Med. Food 15(7), 651-657 (2012